All Targets Achieved
Return to Growth in Q4
- Return to organic revenue growth in Q4 (+1.8%)
- Full-year revenue of €5,648.0 million, down 2.2% relative to 2024 and down 2.2% on an organic basis1 (guidance: “-2.5% to +0.5%”)
- Operating margin on business activity: 9.5%, vs 9.8% in 2024 (guidance: “9.3% to 9.8%”)
- Net profit attributable to the Group up 18.3% to €296.8 million, equating to 5.3% of revenue (2024: 4.3%)
- Basic earnings per share up 22.2% to €15.23
- Free cash flow of €340.9 million, equating to 6.0% of revenue (guidance: “5% to 7%”)
- Proposed dividend in respect of financial year 2025: €5.30 per share (2024: €4.65)
At its meeting on
“I joined
Financial year 2025 unfolded in a challenging environment. Against this backdrop, Sopra Steria’s return to organic growth in the fourth quarter, 18% growth in net profit attributable to the Group and robust cash flow reflect the resilience of our business model and our teams’ high-quality work.
We currently have a solid presence in strategic sectors including defence, aeronautics, the public sector and financial services, and are ramping up in consulting as well as generative and agentic artificial intelligence. These positions are key levers to gradually improve our growth trajectory and margin.
Our solid balance sheet and moderate financial leverage also enable us to enter this new phase with disciplined capital allocation and selectivity in our investments.
We are approaching 2026 with a clear path: securing a lasting return to positive organic growth, improving our operating margin and maintaining a strong cash flow, in line with our medium-term targets. Our priority is to drive long-term value creation for our shareholders and for all our stakeholders.”
|
|
||||||
|
2025 |
2024 reported |
|||||
| Amount | Margin | Change vs 2024 (rep'd) | Amount | Margin | ||
| Key income statement items | ||||||
| Revenue | €m |
5,648.0 |
|
-2.2% |
5,776.8 |
|
| Organic growth | % |
-2.2% |
|
|
|
|
|
|
|
|
|
|||
| Operating profit on business activity | €m |
534.3 |
9.5% |
-5.4% |
564.7 |
9.8% |
| Profit from recurring operations | €m |
491.0 |
8.7% |
-4.7% |
514.9 |
8.9% |
| Operating profit | €m |
441.2 |
7.8% |
-4.1% |
460.3 |
8.0% |
| Net profit attributable to the Group | €m |
296.8 |
5.3% |
18.3% |
251.0 |
4.3% |
|
|
|
|
|
|||
| Weighted average number of shares outstanding excl. treasury shares | m |
19.49 |
|
-3.2% |
20.14 |
|
| Basic earnings per share | € |
15.23 |
|
22.2% |
12.46 |
|
| Basic recurring earnings per share | € |
17.08 |
|
-2.7% |
17.55 |
|
|
|
|
|
|
|||
| Key balance sheet items |
|
|
||||
| Net financial debt | €m |
246.7 |
|
-35.4% |
382.2 |
|
| Equity attributable to the Group | €m |
2,088.8 |
|
8.4% |
1,927.4 |
|
Detailed breakdown of operating performance in 2025
Consolidated revenue totalled €5,648.0 million, down 2.2% compared with 2024. Changes in scope had a €12.2 million positive impact (acquisitions of Aurexia and Neocase). Currency fluctuations had a negative impact of €15.0 million. At constant scope and exchange rates, the contraction in revenue was 2.2%. The scheduled conclusion of the SFT programme3 had a 0.1-point negative impact.
The fourth quarter saw a return to positive growth, with organic revenue growth of 1.8%. This performance was driven by a return to a positive trend in
In 2025, the Group saw a sharp increase in business connected with the roll-out of generative and agentic AI for its clients. In the course of the year, the vast majority of the Group’s key accounts launched one or more AI projects involving
Operating profit on business activity came in at €534.3 million, giving an operating margin on business activity of 9.5% (vs 9.8% in 2024). This included a 0.3-point dilutive effect arising from higher social security contributions announced in
In
In the
In
The Solutions reporting unit (6% of the Group total) posted revenue of €337.6 million, representing organic growth of 2.6%. The Human Resources Solutions business (which accounted for 64% of the reporting unit’s revenue) grew by 3.2%. The reporting unit’s operating margin on business activity came in at 16.7%, up 4.2 points from 2024. All the reporting unit’s businesses (Human Resources, Property Management and Specialised Lending Solutions) contributed to this improvement.
Comments on the components of net profit attributable to the Group in 2025
Profit from recurring operations came to €491.0 million (versus €514.9 million in 2024). It included a €20.5 million share-based payment expense (versus €17.3 million in 2024) and a €22.8 million amortisation expense on allocated intangible assets (versus €32.5 million in 2024).
Operating profit came in at €441.2 million (2024: €460.3 million) after a net expense of €49.8 million for “Other operating income and expenses” (compared with a €54.7 million expense in 2024).
Net interest expense was €38.4 million (versus €38.6 million in 2024).
The tax expense totalled €96.7 million, for an effective tax rate of 24.0%. The normative tax rate, excluding the exceptional additional tax in
Net profit/(loss) from associates amounted to a loss of €1.9 million (compared with a loss of €6.7 million in 2024).
Consolidated net profit came in at €304.2 million, up 17.0%, and net profit attributable to the Group came to €296.8 million, up 18.3%, after deducting €7.4 million attributable to non-controlling interests.
Basic earnings per share came to €15.23, compared with €12.46 in 2024 (up 22.2%).
Workforce
At
The headcount at international service centres totalled 8,484 employees, up 7.6% from 2024, with the proportion of total Group headcount represented by international service centres rising by 1 point to 16.5%.
The employee turnover rate5 was 14.3%, compared with 14.1% in the previous year.
Proposed dividend in respect of financial year 2025
At the next General Meeting of Shareholders, to be held on Wednesday,
Financial position and return on capital employed
Free cash flow was strong at €340.9 million, equating to 6.0% of revenue (2025 guidance: “between 5% and 7%”). This translates into a conversion rate of operating profit on business activity into free cash flow of 63.8%. The working capital requirement came in at -€274.2 million, compared with -€271.1 million in 2024. The 2024 working capital requirement included approximately €45 million in early cash receipts.7
Net financial debt totalled €246.7 million, down 35.4% from its level at
Return on capital employed (RoCE) before tax remained above the medium-term target of 20%, at 20.4% (compared with 21.5% in 2024).
Change in scope
Aurexia, acquired during the financial year and consolidated with effect from
Neocase, acquired during the financial year and consolidated with effect from
On
The proposed acquisition is subject to prior consultation with employee representative bodies as well as customary regulatory approvals and is expected to be completed in the first half of 2026.
Strategy
Social and environmental footprint
With regard to the environment, CDP8 confirmed in
This recognition notably reflects the Group’s Net-Zero target9 of achieving a 54% reduction in its greenhouse gas emissions from Scopes 1 & 2 and a 37.5% reduction for Scope 3 by 2030. As at
In the social arena, the proportion of women in the 3% most senior positions increased 1.0 percentage point in 2025 to 22.4%, while the proportion in the 10% most senior positions increased 0.5 points to 22.8%.
Recap of medium-term financial targets (2026−2028)
- Organic revenue growth of between 2% and 5%
- Operating margin on business activity of between 10% and 11%
- Free cash flow of between 5% and 7% of revenue
Financial targets for 2026
- Organic revenue growth of between 1.0% and 2.0%, including a non-recurring negative impact of around 2 points arising from the conclusion of the SFT programme3
- Operating margin on business activity of at least 9.5%
- Free cash flow of around 5% of revenue
Meeting to report FY 2025 results
The 2025 full-year results will be presented to financial analysts and investors in a French and English webcast on Thursday,
- Register for the French-language webcast here
- Register for the English-language webcast here
Practical information about this presentation can be found in the “Investors” section of the Group’s website: https://www.soprasteria.com/investors
Upcoming financial releases
Wednesday,
Wednesday,
Wednesday,
Thursday,
Glossary
- Restated revenue: Revenue for the prior year, expressed on the basis of the scope and exchange rates for the current year.
- Organic revenue growth: Increase in revenue between the period under review and restated revenue for the same period in the prior financial year.
- EBITDA: This measure, as defined in the Universal Registration Document, is equal to consolidated operating profit on business activity after adding back depreciation, amortisation and provisions included in operating profit on business activity.
- Free cash flow: Free cash flow is defined as net cash from operations; less investments (net of disposals) in property, plant and equipment, and intangible assets; less lease payments; less net interest paid; and less additional contributions to address any deficits in defined-benefit pension plans.
- Operating profit on business activity: This measure, as defined in the Universal Registration Document, is equal to profit from recurring operations adjusted to exclude the share-based payment expense for stock options and free shares and charges to amortisation of allocated intangible assets.
- Profit from recurring operations: This measure is equal to operating profit before other operating income and expenses, which includes any particularly significant items of operating income and expense that are unusual, abnormal, infrequent or not foreseeable, presented separately in order to give a clearer picture of performance based on ordinary activities.
- Basic recurring earnings per share: This measure is equal to basic earnings per share before other operating income and expenses net of tax.
- Return on capital employed (RoCE): (Profit from recurring operations before tax + Profit from equity-accounted companies) / (Equity + Net financial debt)
- Downtime: Number of days between two contracts (excluding training, sick leave, other leave and pre-sales) divided by the total number of business days.
Disclaimer
This document contains forward-looking information subject to certain risks and uncertainties that may affect the Group’s future growth and financial results. Readers are reminded that licence agreements, which often represent investments for clients, are signed in greater numbers in the second half of the year, with varying impacts on end-of-year performance. Actual outcomes and results may differ from those described in this document due to operational risks and uncertainties. More detailed information on the potential risks that may affect the Group’s financial results can be found in the 2024 Universal Registration Document filed with the Autorité des Marchés Financiers (AMF) on
About
The world is how we shape it
For more information, visit us at www.soprasteria.com
Copyright © 2025 Sopra Steria. All rights reserved.
Annexes
|
|
||||
| €m |
2025 |
2024 |
Growth | |
| Revenue |
5,648.0 |
5,776.8 |
-2.2% |
|
| Changes in exchange rates |
-15.0 |
|||
| Revenue at constant exchange rates |
5,648.0 |
5,761.9 |
-2.0% |
|
| Changes in scope |
12.2 |
|||
| Revenue at constant exchange rates, scope and accounting standards |
5,648.0 |
5,774.1 |
-2.2% |
|
|
|
||||
| For €1 / % |
Average rate 2025 |
Average rate 2024 |
Change | |
| Pound sterling |
0.8568 |
0.8466 |
-1.2% |
|
| Norwegian krone |
11.7173 |
11.6290 |
-0.8% |
|
| Swedish krona |
11.0663 |
11.4325 |
+3.3% | |
| Danish krone |
7.4634 |
7.4589 |
-0.1% |
|
| Swiss franc |
0.9370 |
0.9526 |
+1.7% | |
|
|
||||||
| Q4 2025 |
Q4 2024 restated* |
Q4 2024 reported |
Organic growth |
Total growth |
||
|
|
627.2 |
617.4 |
615.4 |
+1.6% |
+1.9% |
|
|
|
242.2 |
222.6 |
234.6 |
+8.8% |
+3.2% |
|
|
|
523.3 |
531.7 |
530.8 |
-1.6% |
-1.4% |
|
| Solutions |
95.8 |
90.9 |
89.7 |
+5.4% |
+6.8% |
|
|
|
1,488.4 |
1,462.6 |
1,470.5 |
+1.8% | +1.2% | |
| * Revenue at 2025 scope and exchange rates | ||||||
|
|
||||||
|
2025 |
2024 restated* |
2024 reported |
Organic growth |
Total growth |
||
|
|
2,409.9 |
2,446.5 |
2,437.9 |
-1.5% |
-1.1% |
|
|
|
909.9 |
950.7 |
962.1 |
-4.3% |
-5.4% |
|
|
|
1,990.6 |
2,048.0 |
2,049.0 |
-2.8% |
-2.9% |
|
| of which: SFT |
162.9 |
170.8 |
170.8 |
-4.6% |
-4.6% |
|
| Solutions |
337.6 |
328.9 |
327.8 |
+2.6% |
+3.0% |
|
|
|
5,648.0 |
5,774.1 |
5,776.8 |
-2.2% |
-2.2% |
|
| of which: SFT |
|
|
|
-0.1% |
-0.1% |
|
| * Revenue at 2025 scope and exchange rates | ||||||
|
|
||||
|
2025 |
2024 reported |
|||
| €m | % | €m | % | |
|
|
||||
| Revenue |
2,409.9 |
2,437.9 |
||
| Operating profit on business activity |
217.5 |
9.0% |
220.4 |
9.0% |
| Profit from recurring operations |
200.3 |
8.3% |
201.6 |
8.3% |
| Operating profit |
184.3 |
7.6% |
182.1 |
7.5% |
|
|
||||
| Revenue |
909.9 |
962.1 |
||
| Operating profit on business activity |
87.4 |
9.6% |
116.9 |
12.1% |
| Profit from recurring operations |
79.1 |
8.7% |
107.8 |
11.2% |
| Operating profit |
74.8 |
8.2% |
100.7 |
10.5% |
|
|
||||
| Revenue |
1,990.6 |
2,049.0 |
||
| Operating profit on business activity |
173.0 |
8.7% |
186.4 |
9.1% |
| Profit from recurring operations |
156.5 |
7.9% |
165.7 |
8.1% |
| Operating profit |
129.2 |
6.5% |
128.5 |
6.3% |
| Solutions | ||||
| Revenue |
337.6 |
327.8 |
||
| Operating profit on business activity |
56.4 |
16.7% |
41.0 |
12.5% |
| Profit from recurring operations |
55.1 |
16.3% |
39.9 |
12.2% |
| Operating profit |
52.9 |
15.7% |
38.0 |
11.6% |
|
|
||||
|
2025 |
2024 reported |
|||
| €m | % | €m | % | |
| Revenue |
5,648.0 |
|
5,776.8 |
|
| Staff costs |
-3,588.8 |
|
-3,611.7 |
|
| Operating expenses |
-1,355.0 |
|
-1,413.6 |
|
| Depreciation, amortisation and provisions |
-169.9 |
|
-186.8 |
|
| Operating profit on business activity |
534.3 |
9.5% |
564.7 |
9.8% |
| Share-based payment expenses |
-20.5 |
|
-17.3 |
|
| Amortisation of allocated intangible assets |
-22.8 |
|
-32.5 |
|
| Profit from recurring operations |
491.0 |
8.7% |
514.9 |
8.9% |
| Other operating income and expenses |
-49.8 |
|
-54.7 |
|
| Operating profit |
441.2 |
7.8% |
460.3 |
8.0% |
| Cost of net financial debt |
-21.1 |
|
-35.4 |
|
| Other financial income and expenses |
-17.3 |
|
-3.2 |
|
| Tax expense |
-96.7 |
|
-96.8 |
|
| Net profit from associates |
-1.9 |
|
-6.7 |
|
| Net profit from continuing operations |
304.2 |
5.4% |
318.2 |
5.5% |
| Net profit from discontinued operations |
- |
|
-58.3 |
|
| Consolidated net profit |
304.2 |
5.4% |
259.9 |
4.5% |
| Attributable to the Group |
296.8 |
5.3% |
251.0 |
4.3% |
| Non-controlling interests |
7.4 |
|
9.0 |
|
| Weighted average number of shares outstanding excluding treasury shares (m) |
19.49 |
|
20.14 |
|
| Basic earnings per share (€) |
15.23 |
|
12.46 |
|
|
|
|||
|
2025 |
2024 reported |
||
| Operating profit on business activity |
534.3 |
564.7 |
|
| Depreciation, amortisation and provisions (excl. allocated intangible assets) |
145.2 |
185.7 |
|
| EBITDA |
679.5 |
750.5 |
|
| Non-cash items |
-4.8 |
-6.0 |
|
| Tax paid |
-79.4 |
-85.7 |
|
| Change in operating working capital requirement |
4.6 |
54.2 |
|
| Reorganisation and restructuring costs |
-50.1 |
-63.6 |
|
| Net cash flow from operations |
549.8 |
649.3 |
|
| Lease payments |
-121.4 |
-127.2 |
|
| Change relating to investing activities |
-56.1 |
-58.3 |
|
| Net interest |
-20.9 |
-21.7 |
|
| Additional contributions related to defined-benefit pension obligations |
-10.5 |
-10.0 |
|
| Free cash flow |
340.9 |
432.1 |
|
| Capital increases |
-0.0 |
-180.0 |
|
| Impact of changes in scope |
-37.7 |
136.7 |
|
| Financial investments |
-3.4 |
2.3 |
|
| Dividends paid |
-92.6 |
-96.3 |
|
| Dividends received |
0.0 |
0.3 |
|
| Purchase and sale of treasury shares |
-63.7 |
-132.4 |
|
| Impact of changes in foreign exchange rates and other |
-8.2 |
-2.2 |
|
| Impact of recognition of SBS net financial debt within “Discontinued operations” |
- |
403.3 |
|
| Change in net financial debt |
135.4 |
563.8 |
|
|
|
|
||
| Net financial debt at beginning of period |
382.2 |
946.0 |
|
| Net financial debt at end of period |
246.7 |
382.2 |
|
|
|
||
|
|
reported |
|
|
|
2,375.6 |
2,348.2 |
| Allocated intangible assets |
151.6 |
174.3 |
| Other fixed assets |
387.5 |
345.2 |
| Right-of-use assets |
385.1 |
384.4 |
| Equity-accounted investments |
1.0 |
1.0 |
| Fixed assets |
3,300.8 |
3,253.0 |
|
|
|
|
| Net deferred tax |
59.5 |
73.1 |
|
|
|
|
| Trade accounts receivable (net) |
1,290.1 |
1,291.4 |
| Other assets and liabilities |
-1,564.3 |
-1,562.5 |
| Working capital requirement (WCR) |
-274.2 |
-271.1 |
| Assets + WCR |
3,086.1 |
3,055.0 |
|
|
|
|
| Equity |
2,147.7 |
1,984.5 |
| Pensions – Post-employment benefits |
158.2 |
135.9 |
| Provisions for contingencies and losses |
106.9 |
125.2 |
| Lease liabilities |
426.5 |
427.3 |
| Net financial debt |
246.7 |
382.2 |
| Capital invested |
3,086.1 |
3,055.0 |
|
|
||
|
|
|
|
|
|
19,962 |
19,949 |
|
|
22,569 |
22,928 |
| Outside |
260 |
224 |
|
|
8,484 |
7,887 |
| Total* |
51,275 |
50,988 |
| * Workforce calculated excluding interns, in accordance with the requirements of the CSRD | ||
| 1 Alternative performance measures are defined at the end of this document. |
| 2 Audit procedures have been carried out and the audit report is being issued. |
|
3 Programme for Sparda banks: operation of system scheduled to end in 2026 following migration, as announced on |
|
4 Workforce excluding interns, in accordance with the requirements of the CSRD. Including interns, the workforce totalled 51,237 at |
| 5 Employee turnover rate including top performers who left less than six months after they were recruited, in accordance with the requirements of the CSRD. |
|
6 20.55 million shares outstanding less 0.86 million bought back under the €150 million share buyback programme completed on |
| 7 The 2024 WCR included exceptional cash receipts totalling approximately €45 million arising from the scheduled conclusion of the SFT programme (see press release of 27 February 2025). |
| 8 Every year, more than 24,800 companies and organisations around the world provide details on their environmental performance to CDP for independent assessment against its scoring methodology for the benefit of investors, purchasers and other stakeholders. |
|
9 Target approved by the Science Based Targets initiative (SBTi) on |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260225261586/en/
Investor Relations
Olivier Psaume
olivier.psaume@soprasteria.com
+33 (0)6 17 64 29 39
Press Relations
caroline.simon@image7.fr
+33 (0)1 53 70 74 65
Source: